Quality Prescribing Guidance for Cardiovascular Risk Reduction 2026-2029

Closes 20 Nov 2026

Implementation of this guidance

We have a few questions, which will help us implement the recommendations from this prescribing guide.

10a. Do you feel there are any barriers to implementing the recommendations from this guidance?
10b. If you answered yes to Question 10a, how do you feel these barriers could be addressed?
10c. What are the key factors that will enable successful implementation of these recommendations?